Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
11/2012
11/29/2012US20120302599 KAT ll INHIBITORS
11/29/2012US20120302584 Novel salts forms of pyrimidin-5-yl acetic acid derivative
11/29/2012US20120302539 Transglutaminase tg2 inhibitors, pharmaceutical compositions, and methods of use thereof
11/29/2012US20120302536 Use of DHEA Derivatives for Enhancing Physical Performance
11/29/2012US20120302491 Modulation of estrogen receptor-related receptor gamma (err gamma) and uses therefor
11/29/2012US20120301507 Method of tissue repair
11/29/2012US20120301472 Reagents and treatment methods for autoimmune diseases
11/29/2012US20120301456 Meganuclease reagents of uses thereof for treating genetic diseases caused by frame shift/non sense mutations
11/29/2012US20120301404 Treatment of cachexia
11/29/2012CA2840336A1 Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome
11/29/2012CA2836503A1 Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
11/28/2012EP2527340A1 Piperazine compound having a pgds inhibitory effect
11/28/2012CN102802729A Liquid dosage forms of isotretinoin
11/28/2012CN102796161A Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors
11/28/2012CN102796160A 17ss-hsd1 and sts inhibitors
11/28/2012CN102793882A Traditional Chinese medicine for treatment of myasthenia gravis
11/28/2012CN102793712A Application of chrysin in preparation of medicaments for treating autoimmune and inflammatory diseases
11/28/2012CN102793693A Applications of vorinostat in aspect of drugs for treating autoimmune diseases and inflammatory diseases
11/28/2012CN102793690A Application of juglone to preparation of medicament for treating autoimmune and inflammatory diseases
11/28/2012CN102793685A Oral capsule containing pregabalin and preparation method thereof
11/28/2012CN102793661A A liquid product of botulinum a-type toxin
11/28/2012CN102258588B Preparation method of peony general glycoside
11/28/2012CN101829291B Traditional Chinese medicine preparation for treating rheumatism and preparation method thereof
11/28/2012CN101778636B Use of 25-hydroxy vitamin d3 to increase muscle mass in mammals
11/28/2012CN101374426B Use of soluble dietary fibres against muscle wasting
11/27/2012US8318744 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
11/27/2012US8318467 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes
11/27/2012US8318173 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits
11/27/2012US8318171 Neurotoxic oligomers
11/22/2012WO2012157746A1 Therapeutic drug for autoimmune disease
11/22/2012WO2012156351A1 Epha4 is a disease modifier in motor neuron disease
11/22/2012WO2012131656A3 Compounds for use as therapeutic agents affecting p53 expression and/or activity
11/22/2012US20120296403 Methods and compounds for muscle growth
11/22/2012US20120295969 Novel Muscle Relaxant Using Negatively Charged Gold with Choline
11/22/2012US20120295888 Use of an adrenal hormone-modifying agent
11/22/2012US20120295884 Complement pathway modulators and uses thereof
11/22/2012US20120294940 Rapidly disintegrating tablet in oral cavity
11/22/2012US20120294906 Sericin extracted fabrics
11/22/2012US20120294895 Protein a compositions and methods of use
11/22/2012US20120294838 Regulation of endogenous gene expression in cells using zinc finger proteins
11/22/2012CA2835798A1 Epha4 is a disease modifier in motor neuron disease
11/21/2012CN102784222A Orally-administrated medicinal liquor for treating chronic lumbar muscle strain
11/21/2012CN102783647A Preparation method of kudzu root isoflavone powder
11/21/2012CN102783646A Preparation method for kudzuvine root flavone lozenge
11/21/2012CN102783639A Cow strong health care capsule and preparation method of cow strong health care capsule
11/21/2012CN102008474B Application of nitidine chloride to preparation of medicament for treating autoimmune disease and graft rejection disease
11/21/2012CN102008468B Application of Incarvillea delavay alkali in preparing drug for resisting autoimmune diseases and graft rejection diseases
11/20/2012US8314067 Relatedness of human interleukin-1β convertase gene to a C. elegans cell death gene, inhibitory portions of these genes and uses therefor
11/20/2012US8314066 GH secretagogues and uses thereof
11/15/2012WO2012153635A1 Therapeutic muscular dystrophy drug having bubble liposome loaded with morpholino as active ingredient
11/15/2012WO2012153191A1 Ncor1 is a physiological modulator of muscle mass and oxidative function
11/15/2012US20120289587 Compounds that modulate intracellular calcium
11/15/2012US20120289536 Pharmaceutical Compositions Comprising Colloidal Silicon Dioxide
11/15/2012US20120289484 Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same
11/15/2012US20120289457 Peptide oligonucleotide conjugates
11/15/2012US20120289452 Compositions and methods for treating and preventing necrosis
11/15/2012US20120288493 Method of inhibitng complement activation with human anti-factor c3 antibodies and use thereof
11/14/2012CN102781518A ACTRIIB antagonists and dosing and uses thereof
11/14/2012CN102781460A Agent for preventing muscular atrophy
11/14/2012CN102781436A Methods for treating fibromyalgia syndrome
11/14/2012CN102775493A IL-1beta binding antibodies and fragments thereof
11/14/2012CN102772408A (1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
11/14/2012CN102772388A Method for preparing flupirtine maleate capsule
11/14/2012CN101993470B Process for preparing high-purity rocuronium
11/14/2012CN101954053B Traditional Chinese medicinal patch and preparation method thereof
11/13/2012CA2575758C Coenzyme q10-containing composition
11/13/2012CA2451643C Antisense modulation of superoxide dismutase 1, soluble expression
11/08/2012WO2012150960A1 Peptide oligonucleotide conjugates
11/08/2012US20120283305 Cysteine protease inhibitors
11/08/2012US20120283238 Irak inhibitors and uses thereof
11/08/2012US20120283217 Modulators of amyloid-beta production
11/08/2012US20120282350 Performance enhancing compositions and methods of use
11/08/2012US20120282232 Nutrient Hydration Bar
11/08/2012US20120282170 Anti- tnf antibodies, compositions, methods and uses
11/08/2012CA2834128A1 Peptide oligonucleotide conjugates
11/07/2012CN102770416A Metaxalone cocrystals
11/07/2012CN102766186A Preparation method and application of ecdysone-rich plant standardized extract
11/07/2012CN102188661B Traditional Chinese medicine for removing arthralgia and preparation method thereof
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/06/2012CA2534358C Bowman-birk inhibitor compositions for treatment of muscular atrophy and degenerative muscle disease
11/06/2012CA2495685C Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
11/01/2012WO2012147597A1 Camptocormia therapeutic agent
11/01/2012WO2012147470A1 Peptide for inducing regeneration of tissue and use thereof
11/01/2012WO2012097330A3 Compositions and methods for treating degenerative muscle conditions
11/01/2012US20120277284 Modulation of signal transducer and activator of transcription 3 (stat3)expression
11/01/2012US20120277259 Substituted benzofused derivatives and their use as vanilloid receptor ligands
11/01/2012US20120277201 Use of hydroxyprogesterone derivatives for enhancing health and physical performance
11/01/2012US20120277146 Compounds For Enzyme Inhibition
11/01/2012US20120276216 Therapeutic Water Treatment
11/01/2012US20120276215 Therapeutic Conditioned Media
11/01/2012US20120276049 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences
11/01/2012CA2834255A1 Peptide for inducing regeneration of tissue and use thereof
10/2012
10/31/2012EP2518054A1 Amide compound
10/31/2012EP2516393A1 Carboxamide compounds and their use as calpain inhibitors
10/31/2012CN102755633A Application of human recombinant protein PDCD5 to treatment of autoimmune disease
10/31/2012CN102755604A Health-care product for restraining hiccup
10/31/2012CN102755320A Medicine composition and healthcare food for treating arthritis
10/31/2012CN102755315A Application of ginkgoneolic acid in preparing medicines for treating immunological diseases
10/31/2012CN102028872B Orally-taken traditional Chinese medicine for treating acute lumbar muscle sprain and preparation method thereof
10/26/2012WO2012144906A1 New compounds for treating, delaying and/or preventing a human genetic disorder such as myotonic dystrophy type 1 (dm1)
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 233